. . . . . "Isoxsuprine" . . . "hypertension" . . . "peripheral vascular disease" . . . "arteriosclerosis obliterans" . . . "Raynaud's disease" . . . "Buerger's disease" . "thromboangiitis obliterans" . . . "cerebrovascular insufficiency" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2022-10-13T12:33:15.239852"^^ . . " Isoxsuprine is a beta-adrenergic agonist used in the symptomatic treatment of cerebrovascular insufficiency, peripheral vascular disease of arteriosclerosis obliterans, thromboangiitis obliterans (Buerger's disease) and Raynaud's disease. It is also used to treat neuroleptic shock, hypertension and neuroleuropathy." . "2.3.0" . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" . "HsxbH1Ipm65s0Vg1QUSuSSGTT7kpN/iNmk0Mbbl8rVXuLrESnj9hCtSsYHrxvwspMFFkTFk5/kI0V2Z/ZlKtU5ppMj36AohvK6Aca7N101Q2w3wRQ2BURUZwm5DwHc/cC7HOIXdRizL5MlBqZLEiy191V08iArzM+RhXbnnbQuJNJDkw/sBLQiOzgHFNimRHN6NSuEUBkOaH5wMEgqlxJ1ntogxPud1rqsVNubCaSCWTxVu4FS3KyVwdURKtvj8CT0G7AoEOrKTw8nXezfFcNiDVZ14KesZz9D6BgvSSSJiH+F/Ezv4lL6+d9s3ml7vj3DFEFN+FR0rRLqXIAIJ/3Q==" . . "2022-10-13T12:33:15.239852"^^ . .